The estimated Net Worth of Donald Allen Williams is at least $377 Thousand dollars as of 12 March 2019. Mr. Williams owns over 4,000 units of Alphatec Inc stock worth over $253,060 and over the last 9 years he sold ATEC stock worth over $0. In addition, he makes $124,036 as Independent Director at Alphatec Inc.
Sign up
Mr. Williams ATEC stock SEC Form 4 insiders trading
Donald has made over 2 trades of the Alphatec Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 4,000 units of ATEC stock worth $9,880 on 12 March 2019.
The largest trade he's ever made was buying 5,000 units of Alphatec Inc stock on 5 May 2015 worth over $6,600. On average, Donald trades about 900 units every 141 days since 2015. As of 12 March 2019 he still owns at least 46,433 units of Alphatec Inc stock.
You can see the complete history of Mr. Williams stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Donald Williams biography
Donald A. Williams serves as Independent Director of the Company. Mr. Williams is a 36-year veteran of the public accounting industry, having spent 18 years as a Partner with Ernst & Young LLP and seven years as a partner with Grant Thornton LLP. Mr. Williams’ career focused on private and public companies in the life sciences and technology industry sectors. During his time at Grant Thornton from 2007 to 2014, he served as the national leader of Grant Thornton’s life sciences practice and the managing partner of the San Diego Office. He was the lead partner for both Ernst & Young and Grant Thornton on multiple initial public offerings, secondary offerings, private and public debt financings, as well as numerous mergers and acquisitions. From 2001 to 2014, Mr. Williams served on the Board of Directors and is past President and Chairman of the San Diego Venture Group. Mr. Williams also serves as a director of Akari Therapeutics Plc, a clinical stage biopharmaceutical company, ImpediMed Ltd, a company that develops bioimpedance devices and Leading Biosciences, a clinical stage bio pharmaceutical company. Mr. Williams earned a B.S. degree from Southern Illinois University.
What is the salary of Donald Williams?
As the Independent Director of Alphatec Inc, the total compensation of Donald Williams at Alphatec Inc is $124,036. There are 7 executives at Alphatec Inc getting paid more, with Patrick Miles having the highest compensation of $7,960,100.
How old is Donald Williams?
Donald Williams is 61, he's been the Independent Director of Alphatec Inc since 2017. There are 3 older and 22 younger executives at Alphatec Inc. The oldest executive at Alphatec Holdings Inc is Ward Woods, 77, who is the Independent Director.
What's Donald Williams's mailing address?
Donald's mailing address filed with the SEC is C/O ALPHATEC SPINE, INC., 1950 CAMINO VIDA ROBLE, CARLSBAD, CA, 92008.
Insiders trading at Alphatec Inc
Over the last 18 years, insiders at Alphatec Inc have traded over $1,216,108,242 worth of Alphatec Inc stock and bought 24,460,197 units worth $141,338,962 . The most active insiders traders include Mortimer Iii Berkowitz, John Foster, and Llc Hgp. On average, Alphatec Inc executives and independent directors trade stock every 24 days with the average trade being worth of $1,610,824. The most recent stock trade was executed by Evan Bakst on 23 August 2024, trading 35,000 units of ATEC stock currently worth $201,600.
What does Alphatec Inc do?
as a medical technology company, we improve lives by providing innovative spine surgery solutions through our relentless pursuit of superior outcomes. we are dedicated to the design, development, launch and the delivery of spinal fusion products. we seek to accomplish this by working with spine surgeons to design and develop products and systems that address the entire spinal fusion procedure in the most effective and efficient way possible. our product designs and platforms provide innovation through a focus on simplifying procedures for the surgeon with the ultimate objective of superior outcomes. alphatec spine is seeking growth through innovation and continually developing technologies that will have a greater positive impact on patient care and outcomes. please visit our website for more information: www.alphatecspine.com
What does Alphatec Inc's logo look like?
Complete history of Mr. Williams stock trades at Akari Therapeutics Plc and Alphatec Inc
Alphatec Inc executives and stock owners
Alphatec Inc executives and other stock owners filed with the SEC include:
-
Patrick Miles,
Chairman of the Board, President, Chief Executive Officer -
David Sponsel,
Executive Vice President - Sales -
Jeffrey Black,
Chief Financial Officer, Executive Vice President -
Patrick S. Miles,
Exec. Chairman, CEO & Pres -
Craig Hunsaker,
Executive Vice President - People & Culture, General Counsel -
David P. Sponsel,
Exec. VP of Sales -
Craig E. Hunsaker,
Exec. VP of People & Culture, Corp. Sec. and Gen. Counsel -
Donald Williams,
Independent Director -
Ward Woods,
Independent Director -
Quentin Blackford,
Independent Director -
David Mowry,
Independent Director -
Jeffrey Rydin,
Director -
James Tullis,
Independent Director -
Jason Hochberg,
Independent Director -
Evan Bakst,
Independent Director -
Karen McGinnis,
Independent Director -
Josh Berg,
IR Contact Officer -
David Pelizzon,
Director -
Mortimer Berkowitz,
Lead Independent Director -
Mark Ojeda,
Executive Vice President - Cervical & Biologics -
Kelli Howell,
Executive Vice President - Clinical Strategies -
Eric Dasso,
Executive Vice President - Adjunctive Technologies -
Brian Snider,
Executive Vice President - Marketing and Development -
Mark D. Ojeda,
Exec. VP of Cervical & Biologics -
Kelli Mari Howell,
Exec. VP of Clinical Strategies -
Dr. Luiz Pimenta,
Chief Medical Officer -
Jonathan Allen,
Exec. VP of Commercial Operations -
Brian R. Snider,
Exec. VP of Marketing -
Scott Lish,
Sr. VP of R&D -
J. Todd Koning,
Chief Financial Officer -
Terry M. Rich,
President & COO -
Leslie H Cross,
Director -
Dennis Nelson,
VP, Finance and Controller -
Stephen Oneil,
Director -
Siri S Marshall,
Director -
R Ian Molson,
Director -
James Corbett,
President and CEO -
Jonathan Allen,
EVP, Commerical Operations -
Michael Joseph Plunkett,
Chief Operating Officer -
Michael O'neill,
CFO and Vice President -
John Foster,
Director -
Ebun Garner,
VP, Legal Affairs & Compliance -
Jennifer N. Pritzker,
10% owner -
David M Demski,
-
Keith Valentine,
-
Healthcare Partners, Llc Se...,
-
Mitsuo Asai,
President, Alphatec Pacific -
Tom C Davis,
Director -
James R Glynn,
Director -
Rohit M Desai,
Director -
Luke T Faulstick,
Director -
William Patrick Ryan,
Chief Operating Officer -
Partners Ii L P Healthpoint...,
10% owner -
Ii, Llc Hgp,
10% owner -
Ross Simmonds,
Senior VP, Sales & Marketing -
Stephen Lubischer,
VP, Sales -
Reinecke Steven,
VP, Research & Development -
Richard Ravitch,
Director -
Oliver Burckhardt,
President, International -
Kermit P. Stott,
VP, Operations -
Co Invest Vehicle Ii, L.P. ...,
10% owner -
Peter C Wulff,
CFO, VP and Treasurer -
Dirk Kuyper,
President and CEO -
Brian Plotkin,
VP, Information Technology -
Jens Peter Timm,
VP, Research and Development -
Stephen Hochschuler,
Director -
Corp Chubb,
10% owner -
Partners Lp Healthpoint Cap...,
10% owner -
Llc Hgp,
10% owner -
Ii, Llchealthpointcapital P...,
-
Herbert J Bellucci,
VP, Manufacturing -
Stephen T D Dixon,
CFO, VP and Treasurer -
Vicky Romanoski,
Chief Admin Ofcr, VP & Scrty -
Insurance Co Federal,
10% owner -
Daniel Lacienski,
Executive VP, Operations -
Kimberly Bradshaw,
VP, Physician Services -
Steven Yasbek,
CFO, Treasurer and V.P. -
Shunshiro Yoshimi,
-
Ronald Hiscock,
President & CEO -
Scott Weise,
VP, Business Dev. & Marketing -
Trent Northcutt,
VP, Sales -
John Todd Koning,
CHIEF FINANCIAL OFFICER -
Marie Meynadier,
-
Elizabeth Ann Altman,
-
Paul Segal,
-
Tyson Eliot Marshall,
GENERAL COUNSEL & CORP. SEC. -
Andy Barnett,
Director -
Scott Lish,
CHIEF OPERATING OFFICER